BSEPhaarmasia Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 28 May, 2025 · 16:59 IST

Financial Results Declaration

Revenue DeclinePat NegativeEbitda Margin CompressionNegative Operating CashflowResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.9%Reaction day
₹28.22
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.3% vs market
Pharmaceuticals peers, median of 147sector+0.5%-2.4% vs sector

On the reaction day the stock moved 2.3 pts less than Nifty Microcap 250 and 2.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.9+0.4-2.3+0.5-2.4
Next day
-3.9+0.7-4.5-0.2-3.7
2d
-3.9+0.7-4.6-0.3-3.5
3d
-4.3+0.5-4.8-0.4-3.9
4d
-4.3+1.0-5.3-0.1-4.2
5d
-2.4+1.5-3.9-0.1-2.3
1w
+4.5+2.8+1.7+0.4+4.1
15d
+20.5-0.7+21.2-3.0+23.5
1m
+24.9+3.7+21.2-0.2+25.1
2m
—+3.0—+1.3—
3m
+13.4-1.4+14.9-4.2+17.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Phaarmasia Limited announced its audited financial results for FY25, reporting revenue from operations of ₹2,436.88 lakhs, down from ₹3,059.33 lakhs in FY24 — a decline of about 20.3%. The company slipped deeper into the red with a net loss of ₹(158.94) lakhs versus ₹(51.82) lakhs in the previous year, and loss before tax widened to ₹(160.27) lakhs from ₹(54.59) lakhs. Basic EPS worsened to ₹(2.33) from ₹(0.76). The balance sheet shrank — total assets fell to ₹2,156.01 lakhs from ₹3,144.78 lakhs, largely on lower inventories, receivables, and payables. Cash from operations was effectively negative at ₹(0.36) lakhs, and closing cash dropped to ₹36.42 lakhs. The statutory auditor, Sathuluri & Co, issued an unmodified (clean) opinion.

Likely market impact

Sharply falling revenue combined with widening losses and a shrinking balance sheet signals ongoing operational stress for shareholders, though the clean audit opinion removes any immediate governance red flag.